Novobiocin Competitive Antibody Pair

AccuSift
NBC
SKU Name Unit Price Delivery QTY
SR306 Novobiocin monoclonal antibody 1mg $750 10days
TC306 Novobiocin BSA antigen 1mg $300 10days
AccuSift provides high-performance novobiocin competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Novobiocin is a coumarin-class antibiotic that inhibits DNA gyrase. It was discovered in 1955 simultaneously by three pharmaceutical laboratories in the United States and exhibits significant efficacy against staphylococcal infections. It is primarily excreted unchanged by the kidneys (excretion rate ~80%) and has a plasma elimination half-life ≤1 hour. Its antibacterial spectrum is similar to that of penicillin, and it is used for infections caused by penicillin-resistant Staphylococcus aureus, such as pneumonia and septicemia.
Performance Characteristics:

  • Sensitivity: ELISA IC50: 7 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long-term storage at ≤ –20°C; short-term storage at 2–8°C. Shipped on ice packs.


Operation

References